Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 16, 2015 - Issue 1-2
Submit an article Journal homepage
543
Views
61
CrossRef citations to date
0
Altmetric
BIOMARKER

Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia

Barbara BorroniCentre of Neurodegenerative Disorders, Neurology Unit, University of Brescia, Brescia, ItalyCorrespondence[email protected]
,
Alberto BenussiCentre of Neurodegenerative Disorders, Neurology Unit, University of Brescia, Brescia, Italy
,
Silvana ArchettiIII Laboratory of Analysis, Brescia Hospital, Brescia, Italy
,
Daniela GalimbertiDino Ferrari Centre, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Policlinico, Department of Neurological Sciences, Milan, Italy
,
Lucilla ParnettiSection of Neurology, Centre for Memory Disturbances, University of Perugia, Perugia, Italy
,
Benedetta NacmiasDepartment of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy
,
Sandro SorbiDepartment of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy
,
Elio ScarpiniDino Ferrari Centre, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Policlinico, Department of Neurological Sciences, Milan, Italy
&
Alessandro PadovaniCentre of Neurodegenerative Disorders, Neurology Unit, University of Brescia, Brescia, Italy
 show all
Pages 86-91 | Received 03 Jul 2014, Accepted 28 Sep 2014, Published online: 29 Oct 2014

Citations (61)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Nicole Campese, Giovanni Palermo, Claudia Del Gamba, Maria Francesca Beatino, Alessandro Galgani, Elisabetta Belli, Eleonora Del Prete, Alessandra Della Vecchia, Andrea Vergallo, Gabriele Siciliano, Roberto Ceravolo, Harald Hampel & Filippo Baldacci. (2021) Progress regarding the context-of-use of tau as biomarker of Alzheimer’s disease and other neurodegenerative diseases. Expert Review of Proteomics 18:1, pages 27-48.
Read now
Maura Cosseddu, Alberto Benussi, Stefano Gazzina, Rosanna Turrone, Silvana Archetti, Elisa Bonomi, Giorgio Biasiotto, Isabella Zanella, Raffaele Ferrari, Maria S. Cotelli, Antonella Alberici, Alessandro Padovani & Barbara Borroni. (2018) Mendelian forms of disease and age at onset affect survival in frontotemporal dementia. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:1-2, pages 87-92.
Read now

Articles from other publishers (59)

Elena Fontana, Matilde Bongianni, Alberto Benussi, Erika Bronzato, Carlo Scialo, Luca Sacchetto, Annachiara Cagnin, Santina Castriciano, Emanuele Buratti, Fabrizio Gardoni, Maria Italia, Alberto Schreiber, Chiara Ferracin, Michele Fiorini, Kathy L. Newell, Laura Cracco, Holly J. Garringer, Maria Paola Cecchini, Magdalini Polymenidou, Alessandro Padovani, Salvatore Monaco, Giuseppe Legname, Bernardino Ghetti, Barbara Borroni & Gianluigi Zanusso. (2023) Detection of TDP‐43 seeding activity in the olfactory mucosa from patients with frontotemporal dementia. Alzheimer's & Dementia.
Crossref
Roxane Dilcher, Charles B. Malpas, Terence J. O’Brien & Lucy Vivash. (2023) Social Cognition in Behavioral Variant Frontotemporal Dementia and Pathological Subtypes: A Narrative Review. Journal of Alzheimer's Disease 94:1, pages 19-38.
Crossref
Iddo Magen, Nancy‐Sarah Yacovzada, Jason D. Warren, Carolin Heller, Imogen Swift, Yoana Bobeva, Andrea Malaspina, Jonathan D. Rohrer, Pietro Fratta & Eran Hornstein. (2023) microRNA‐based predictor for diagnosis of frontotemporal dementia. Neuropathology and Applied Neurobiology.
Crossref
Abbott Gifford, Nathan Praschan, Amy Newhouse & Zeina Chemali. (2023) Biomarkers in frontotemporal dementia: Current landscape and future directions. Biomarkers in Neuropsychiatry 8, pages 100065.
Crossref
Kanta Horie, Nicolas R. Barthélemy, Salvatore Spina, Lawren VandeVrede, Yingxin He, Ross W. Paterson, Brenton A. Wright, Gregory S. Day, Albert A. Davis, Celeste M. Karch, William W. Seeley, Richard J. Perrin, Rama K. Koppisetti, Faris Shaikh, Argentina Lario Lago, Hilary W. Heuer, Nupur Ghoshal, Audrey Gabelle, Bruce L. Miller, Adam L. Boxer, Randall J. Bateman & Chihiro Sato. (2022) CSF tau microtubule-binding region identifies pathological changes in primary tauopathies. Nature Medicine 28:12, pages 2547-2554.
Crossref
Nastaran Karimi, Feyza Bayram Çatak, Ebru Arslan, Amene Saghazadeh & Nima Rezaei. (2022) Tau immunotherapy in Alzheimer’s disease and progressive supranuclear palsy. International Immunopharmacology 113, pages 109445.
Crossref
Zhongying Gong, Lina Gao, Yi Lu & Zhiyun Wang. (2022) CSF p-tau as a potential cognition impairment biomarker in ALS. Frontiers in Neurology 13.
Crossref
Marta del Campo, Henrik Zetterberg, Sam Gandy, Chiadi U Onyike, Fabricio Oliveira, Chi Udeh‐Momoh, Alberto Lleó, Charlotte E. Teunissen & Yolande Pijnenburg. (2022) New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia. Alzheimer's & Dementia 18:11, pages 2292-2307.
Crossref
Katheryn A. Q. Cousins, Leslie M. Shaw, Alice Chen-Plotkin, David A. Wolk, Vivianna M. Van Deerlin, Edward B. Lee, Corey T. McMillan, Murray Grossman & David J. Irwin. (2022) Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers. JAMA Neurology 79:11, pages 1155.
Crossref
Elisabeth Kapaki, Foteini Boufidou, Mara Bourbouli, Efstratios-Stylianos Pyrgelis, Vasilios C. Constantinides, Cleo Anastassopoulou & George P. Paraskevas. (2022) Cerebrospinal Fluid Biomarker Profile in TDP-43-Related Genetic Frontotemporal Dementia. Journal of Personalized Medicine 12:10, pages 1747.
Crossref
Manuela Tondelli, Simone Salemme, Giulia Vinceti, Roberta Bedin, Tommaso Trenti, Maria Angela Molinari, Annalisa Chiari & Giovanna Zamboni. (2022) Predictive value of phospho-tau/total-tau ratio in amyloid-negative Mild Cognitive Impairment. Neuroscience Letters 787, pages 136811.
Crossref
Marta Pengo, Antonella Alberici, Ilenia Libri, Alberto Benussi, Yasmine Gadola, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow & Barbara Borroni. (2022) Sex influences clinical phenotype in frontotemporal dementia. Neurological Sciences 43:9, pages 5281-5287.
Crossref
Roxane Dilcher, Charles B. Malpas, Mark Walterfang, Dennis Velakoulis, Terence J. O’Brien & Lucy Vivash. (2022) Sodium selenate as a therapeutic for tauopathies: A hypothesis paper. Frontiers in Aging Neuroscience 14.
Crossref
Jared S. Katzeff, Fiona Bright, Katherine Phan, Jillian J. Kril, Lars M. Ittner, Michael Kassiou, John R. Hodges, Olivier Piguet, Matthew C. Kiernan, Glenda M. Halliday & Woojin Scott Kim. (2022) Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis. Brain 145:5, pages 1598-1609.
Crossref
Maria Carmela Tartaglia & Ian R. A. Mackenzie. (2022) Recent Advances in Frontotemporal Dementia. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, pages 1-10.
Crossref
Eleonora Virgilio, Fabiola De Marchi, Elena Contaldi, Umberto Dianzani, Roberto Cantello, Letizia Mazzini & Cristoforo Comi. (2022) The Role of Tau beyond Alzheimer’s Disease: A Narrative Review. Biomedicines 10:4, pages 760.
Crossref
David Reyes-Leiva, Oriol Dols-Icardo, Sonia Sirisi, Elena Cortés-Vicente, Janina Turon-Sans, Noemi de Luna, Rafael Blesa, Olivia Belbin, Victor Montal, Daniel Alcolea, Juan Fortea, Alberto Lleó, Ricard Rojas-García & Ignacio Illán-Gala. (2022) Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies. Frontiers in Neurology 12.
Crossref
Alberto Benussi, Ilenia Libri, Enrico Premi, Antonella Alberici, Valentina Cantoni, Yasmine Gadola, Jasmine Rivolta, Marta Pengo, Stefano Gazzina, Vince D. Calhoun, Roberto Gasparotti, Henrik Zetterberg, Nicholas J. Ashton, Kaj Blennow, Alessandro Padovani & Barbara Borroni. (2022) Differences and similarities between familial and sporadic frontotemporal dementia: An Italian single‐center cohort study. Alzheimer's & Dementia: Translational Research & Clinical Interventions 8:1.
Crossref
Alberto Benussi, Nicholas J. Ashton, Thomas K. Karikari, Antonella Alberici, Claudia Saraceno, Roberta Ghidoni, Luisa Benussi, Henrik Zetterberg, Kaj Blennow & Barbara Borroni. (2021) Prodromal frontotemporal dementia: clinical features and predictors of progression. Alzheimer's Research & Therapy 13:1.
Crossref
Chihiro Sato, Nipun Mallipeddi, Nupur Ghoshal, Brenton A. Wright, Gregory S. Day, Albert A. Davis, Albert H. Kim, Gregory J. Zipfel, Randall J. Bateman, Audrey Gabelle & Nicolas R. Barthélemy. (2021) MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology . Annals of Clinical and Translational Neurology 8:9, pages 1817-1830.
Crossref
Magdalena Bruzova, Robert Rusina, Zuzana Stejskalova & Radoslav Matej. (2021) Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up. Scientific Reports 11:1.
Crossref
Emma L. van der Ende & John C. van Swieten. 2021. Frontotemporal Dementias. Frontotemporal Dementias 123 139 .
Enrico Premi, Viviana Cristillo, Stefano Gazzina, Alberto Benussi, Antonella Alberici, Maria Sofia Cotelli, Vince D. Calhoun, Armin Iraji, Mauro Magoni, Maria Cotelli, Anna Micheli, Roberto Gasparotti, Alessandro Padovani & Barbara Borroni. (2020) Expanding the role of education in frontotemporal dementia: a functional dynamic connectivity (the chronnectome) study. Neurobiology of Aging 93, pages 35-43.
Crossref
Orit H. Lesman-Segev, Lauren Edwards & Gil D. Rabinovici. (2020) Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia. Seminars in Neurology 40:04, pages 394-410.
Crossref
Francesco Panza, Madia Lozupone, Davide Seripa, Antonio Daniele, Mark Watling, Gianluigi Giannelli & Bruno P. Imbimbo. (2020) Development of disease-modifying drugs for frontotemporal dementia spectrum disorders. Nature Reviews Neurology 16:4, pages 213-228.
Crossref
Alberto Benussi, Valentina Dell’Era, Valentina Cantoni, Maria Sofia Cotelli, Maura Cosseddu, Marco Spallazzi, Anna Micheli, Rosanna Turrone, Antonella Alberici & Barbara Borroni. (2020) TMS for staging and predicting functional decline in frontotemporal dementia. Brain Stimulation 13:2, pages 386-392.
Crossref
Alberto Benussi, Mario Grassi, Fernando Palluzzi, Giacomo Koch, Vincenzo Di Lazzaro, Raffaele Nardone, Valentina Cantoni, Valentina Dell'Era, Enrico Premi, Alessandro Martorana, Francesco Lorenzo, Sonia Bonnì, Federico Ranieri, Fioravante Capone, Gabriella Musumeci, Maria Sofia Cotelli, Alessandro Padovani & Barbara Borroni. (2020) Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias. Annals of Neurology 87:3, pages 394-404.
Crossref
Alberto Benussi, Valentina Dell’Era, Valentina Cantoni, Maria Sofia Cotelli, Maura Cosseddu, Marco Spallazzi, Antonella Alberici, Alessandro Padovani & Barbara Borroni. (2020) Neurophysiological Correlates of Positive and Negative Symptoms in Frontotemporal Dementia. Journal of Alzheimer's Disease 73:3, pages 1133-1142.
Crossref
Mélanie Brisson, Catherine Brodeur, Laurent Létourneau‐Guillon, Mario Masellis, Jon Stoessl, Alex Tamm, Katherine Zukotynski, Zahinoor Ismail, Serge Gauthier, Pedro Rosa‐Neto & Jean‐Paul Soucy. (2021) CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment. Alzheimer's & Dementia: Translational Research & Clinical Interventions 6:1.
Crossref
Alberto Benussi, Valentina Dell'Era, Maura Cosseddu, Valentina Cantoni, Maria Sofia Cotelli, Maria Cotelli, Rosa Manenti, Luisa Benussi, Chiara Brattini, Antonella Alberici & Barbara Borroni. (2020) Transcranial stimulation in frontotemporal dementia: A randomized, double‐blind, sham‐controlled trial. Alzheimer's & Dementia: Translational Research & Clinical Interventions 6:1.
Crossref
Alessandro Padovani, Alberto Benussi, Maria Sofia Cotelli, Clarissa Ferrari, Valentina Cantoni, Valentina Dell’Era, Rosanna Turrone, Barbara Paghera & Barbara Borroni. (2019) Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy. Alzheimer's Research & Therapy 11:1.
Crossref
Daniela Vieira, João Durães, Inês Baldeiras, Beatriz Santiago, Diana Duro, Marisa Lima, Maria João Leitão, Miguel Tábuas-Pereira & Isabel Santana. (2019) Lower CSF Amyloid-Beta1–42 Predicts a Higher Mortality Rate in Frontotemporal Dementia. Diagnostics 9:4, pages 162.
Crossref
Martha S Foiani, Claudia Cicognola, Natalia Ermann, Ione O C Woollacott, Carolin Heller, Amanda J Heslegrave, Ashvini Keshavan, Ross W Paterson, Keqiang Ye, Johannes Kornhuber, Nick C Fox, Jonathan M Schott, Jason D Warren, Piotr Lewczuk, Henrik Zetterberg, Kaj Blennow, Kina Höglund & Jonathan D Rohrer. (2019) Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest. Journal of Neurology, Neurosurgery & Psychiatry 90:7, pages 740-746.
Crossref
Petra Steinacker, Peggy Barschke & Markus Otto. (2019) Biomarkers for diseases with TDP-43 pathology. Molecular and Cellular Neuroscience 97, pages 43-59.
Crossref
Alberto Benussi, Antonella Alberici, Emanuele Buratti, Roberta Ghidoni, Fabrizio Gardoni, Monica Di Luca, Alessandro Padovani & Barbara Borroni. (2019) Toward a Glutamate Hypothesis of Frontotemporal Dementia. Frontiers in Neuroscience 13.
Crossref
Thalia T Robey & Peter K Panegyres. (2019) Cerebrospinal fluid biomarkers in neurodegenerative disorders. Future Neurology 14:1, pages FNL6.
Crossref
Franc Llorens, Anna Villar-Piqué, Niccolò Candelise, Isidre Ferrer & Inga Zerr. 2019. Cognitive Disorders. Cognitive Disorders.
Barbara Borroni & Alberto Benussi. (2019) Recent advances in understanding frontotemporal degeneration. F1000Research 8, pages 2098.
Crossref
Alberto Benussi, Antonella Alberici, Clarissa Ferrari, Valentina Cantoni, Valentina Dell’Era, Rosanna Turrone, Maria Sofia Cotelli, Giuliano Binetti, Barbara Paghera, Giacomo Koch, Alessandro Padovani & Barbara Borroni. (2018) The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease. Alzheimer's Research & Therapy 10:1.
Crossref
Joery Goossens, Maria Bjerke, Sara Van Mossevelde, Tobi Van den Bossche, Johan Goeman, Bart De Vil, Anne Sieben, Jean-Jacques Martin, Patrick Cras, Peter Paul De Deyn, Christine Van Broeckhoven, Julie van der Zee & Sebastiaan Engelborghs. (2018) Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. Alzheimer's Research & Therapy 10:1.
Crossref
Samir Abu-Rumeileh, Nicola Mometto, Anna Bartoletti-Stella, Barbara Polischi, Federico Oppi, Roberto Poda, Michelangelo Stanzani-Maserati, Pietro Cortelli, Rocco Liguori, Sabina Capellari & Piero Parchi. (2018) Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study. Journal of Alzheimer's Disease 66:2, pages 551-563.
Crossref
Marta del Campo, Daniela Galimberti, Naura Elias, Lynn Boonkamp, Yolande A. Pijnenburg, John C. van Swieten, Kelly Watts, Silvia Paciotti, Tommaso Beccari, William Hu & Charlotte E. Teunissen. (2018) Novel CSF biomarkers to discriminate FTLD and its pathological subtypes. Annals of Clinical and Translational Neurology 5:10, pages 1163-1175.
Crossref
Alessandro Padovani, Alberto Benussi, Valentina Cantoni, Valentina Dell’Era, Maria Sofia Cotelli, Salvatore Caratozzolo, Rosanna Turrone, Luca Rozzini, Antonella Alberici, Daniele Altomare, Alessandro Depari, Alessandra Flammini, Giovanni B. Frisoni & Barbara Borroni. (2018) Diagnosis of Mild Cognitive Impairment Due to Alzheimer’s Disease with Transcranial Magnetic Stimulation. Journal of Alzheimer's Disease 65:1, pages 221-230.
Crossref
Lieke H.H. MeeterEverard G. VijverbergMarta Del CampoAnnemieke J.M. RozemullerLaura Donker KaatFrank Jan de JongWiesje M. van der FlierCharlotte E. TeunissenJohn C. van SwietenYolande A.L. Pijnenburg. (2018) Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum. Neurology 90:14.
Crossref
Barbara Borroni, Alberto Benussi, Enrico Premi, Antonella Alberici, Elena Marcello, Fabrizio Gardoni, Monica Di Luca & Alessandro Padovani. (2018) Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin. Journal of Alzheimer's Disease 62:3, pages 1113-1123.
Crossref
Niklas Mattsson, Sotirios Grigoriou & Henrik Zetterberg. 2018. Neurodegenerative Diseases. Neurodegenerative Diseases 221 252 .
Andrea Vergallo, Cecilia Carlesi, Cristina Pagni, Filippo Sean Giorgi, Filippo Baldacci, Lucia Petrozzi, Roberto Ceravolo, Gloria Tognoni, Gabriele Siciliano & Ubaldo Bonuccelli. (2017) A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting. Neurological Sciences 38:10, pages 1791-1797.
Crossref
David Coughlin & David J. Irwin. (2017) Emerging Diagnostic and Therapeutic Strategies for Tauopathies. Current Neurology and Neuroscience Reports 17:9.
Crossref
Alberto BenussiFrancesco Di LorenzoValentina Dell'EraMaura CossedduAntonella AlbericiSalvatore CaratozzoloMaria Sofia CotelliAnna MicheliLuca RozziniAlessandro DepariAlessandra FlamminiViviana PonzoAlessandro MartoranaCarlo CaltagironeAlessandro PadovaniGiacomo KochBarbara Borroni. (2017) Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia. Neurology 89:7, pages 665-672.
Crossref
Lieke H. Meeter, Laura Donker Kaat, Jonathan D. Rohrer & John C. van Swieten. (2017) Imaging and fluid biomarkers in frontotemporal dementia. Nature Reviews Neurology 13:7, pages 406-419.
Crossref
Carlo Wilke, Frank Gillardon, Christian Deuschle, Markus A. Hobert, Iris E. Jansen, Florian G. Metzger, Peter Heutink, Thomas Gasser, Walter Maetzler, Cornelis Blauwendraat & Matthis Synofzik. (2017) Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in <b><i>GRN</i></b>-Negative Frontotemporal Dementia. Neurodegenerative Diseases 17:2-3, pages 83-88.
Crossref
Everard G.B. Vijverberg, Annemiek Dols, Welmoed A. Krudop, Marta Del Campo Milan, Cora J. Kerssens, Flora Gossink, Niels D. Prins, Max L. Stek, Philip Scheltens, Charlotte E. Teunissen & Yolande A.L. Pijnenburg. (2017) Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 7:1, pages 99-106.
Crossref
George P. Paraskevas, Dimitrios Kasselimis, Evie Kourtidou, Vasilios Constantinides, Anastasia Bougea, Costas Potagas, Ioannis Evdokimidis & Elisabeth Kapaki. (2016) Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia. Journal of Alzheimer's Disease 55:4, pages 1453-1461.
Crossref
H. Bea Kuiperij, Alexandra A.M. Versleijen, Marijke Beenes, Nicolaas A. Verwey, Luisa Benussi, Anna Paterlini, Giuliano Binetti, Charlotte E. Teunissen, Joost Raaphorst, Helenius J. Schelhaas, Benno Küsters, Yolande A.L. Pijnenburg, Roberta Ghidoni & Marcel M. Verbeek. (2016) Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study. Journal of Alzheimer's Disease 55:2, pages 585-595.
Crossref
Patrick Oeckl, Petra Steinacker, Emily Feneberg & Markus Otto. (2016) Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update. Journal of Neurochemistry 138, pages 184-192.
Crossref
A. Eusebio, L. Koric, O. Félician, E. Guedj, M. Ceccaldi & J.-P. Azulay. (2016) Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations. Revue Neurologique 172:8-9, pages 488-502.
Crossref
Welmoed A. Krudop, Annemiek Dols, Cora J. Kerssens, Niels D. Prins, Christiane Möller, Sigfried Schouws, Frederik Barkhof, Bart N.M. van Berckel, Charlotte E. Teunissen, Wiesje M. van der Flier, Philip Scheltens, Sietske A.M. Sikkes, Max L. Stek & Yolande A.L. Pijnenburg. (2016) Impact of Imaging and Cerebrospinal Fluid Biomarkers on Behavioral Variant Frontotemporal Dementia Diagnosis within a Late-Onset Frontal Lobe Syndrome Cohort. Dementia and Geriatric Cognitive Disorders 41:1-2, pages 16-26.
Crossref
In?s Baldeiras, Isabel Santana, Maria Jo?o Leit?o, Maria Helena Ribeiro, Rui Pascoal, Diana Duro, Raquel Lemos, Beatriz Santiago, Maria Ros?rio Almeida & Catarina Resende Oliveira. (2015) Cerebrospinal fluid A?40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease. Journal of the Neurological Sciences 358:1-2, pages 308-316.
Crossref
Alberto Benussi, Alessandro Padovani & Barbara Borroni. (2015) Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. Frontiers in Aging Neuroscience 7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.